The second recommendation deals with the initial and maximum doses of methotrexate, time intervals between dose adjustments, and changing from oral to parenteral administration if needed.

Our case series seeks to document the combined experience of the contributing clinicians in the use of oral methotrexate in patients with difficult symptoms from collagenous colitis. We hope this ...

The Food and Drug Administration (FDA) has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia (ALL), as part of a ...

A new study published in the Journal of the European Academy of Dermatology and Venereology found that methotrexate (MTX) has ...

Amgen (AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of ...

This study raises the possibility that oral low-dose methotrexate may be effective in patients with collagenous colitis and may improve the histological abnormalities in some. Side-effects appear ...